Bio-Techne (TECH) Tax Provisions (2009 - 2026)
Bio-Techne (TECH) posted quarterly Tax Provisions of $20.2 million for Q1 2026, up 28.64% year-over-year from $15.7 million in Q1 2025, and up 57.95% quarter-over-quarter from $12.8 million in Q4 2025.
Bio-Techne (TECH) Tax Provisions (2009 - 2026) Analysis & Trends
Bio-Techne's Tax Provisions history runs 18 years deep, the most recent figure standing at $20.2 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 28.64% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $37.6 million (down 47.43% YoY), while the FY2025 annual figure was $25.1 million, down 56.6% from the prior year.
- Tax Provisions for Q1 2026 stood at $20.2 million, up from $12.8 million in the prior quarter.
- The five-year high for Tax Provisions was $41.2 million in Q2 2024, with the low at -$5.2 million in Q2 2025.
- The 5-year median for Tax Provisions is $10.1 million (2022), against an average of $11.6 million.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions soared 18075.0% in 2022, then plunged 112.56% in 2025.
- Bio-Techne's Tax Provisions stood at $16.4 million in 2022, then tumbled by 63.94% to $5.9 million in 2023, then jumped by 34.85% to $8.0 million in 2024, then soared by 59.97% to $12.8 million in 2025, then surged by 57.95% to $20.2 million in 2026.
- Business Quant data shows TECH's Tax Provisions at $20.2 million in Q1 2026, $12.8 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 20.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.18 Mn |
| Dec 31, 2025 | 12.78 Mn |
| Sep 30, 2025 | 9.81 Mn |
| Jun 30, 2025 | -5.18 Mn |
| Mar 31, 2025 | 15.69 Mn |
| Dec 31, 2024 | 7.99 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 41.23 Mn |
| Mar 31, 2024 | 12.03 Mn |
| Dec 31, 2023 | 5.92 Mn |
| Sep 30, 2023 | -1.44 Mn |
| Jun 30, 2023 | 12.83 Mn |
| Mar 31, 2023 | 9.98 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 13.98 Mn |
| Jun 30, 2022 | 10.07 Mn |
| Mar 31, 2022 | 8.63 Mn |
| Dec 31, 2021 | 14.12 Mn |
| Sep 30, 2021 | -1.60 Mn |
| Jun 30, 2021 | 20.48 Mn |